Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache
Growth Hormone & IGF Research · 2015-10 · 25 (5) · 262-267
DOI: 10.1016/j.ghir.2015.07.003 ↗Kurz gefasst
Fallbericht in der Zeitschrift Growth Hormone & IGF Research, 2015-10. Verfasst von Djordje Marina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Endocrinology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Arvid Nilsson's fund.
Abstract (Originalsprache)
BACKGROUND: Somatotropinomas have unique "fingerprints" of somatostatin receptor (sst) expression, which are targets in treatment of acromegaly with somatostatin analogues (SSAs). However, a significant expression of sst is not always related to the biochemical response to SSAs. Headache is a common complaint in acromegaly and considered a clinical marker of disease activity. SSAs are reported to have an own analgesic effect, but the sst involved are unknown. PATIENTS AND METHODS: We investigated sst expression in two acromegalic patients with severe headache and no biochemical effects of octreotide, but a good response to pasireotide. We searched the literature for determinants of biochemical and analgesic effects of SSAs in somatotropinomas. RESULTS: Case 1 had no biochemical or analgesic effects of octreotide, a semi-selective SSA, but a rapid and significant effect of pasireotide, a pan-SSA. Case 2 demonstrated discordance between analgesic and biochemical effects of octreotide, in that headache disappeared, but without biochemical improvement. In contrast, pasireotide normalized insulin-like growth factor 1. Both adenomas were sparsely granulated and had strong membranous expressions of sst2a in 50-75% and sst5 in 75-100% of tumor cells. The truncated sst5 variant TMD4 (sst5TMD4) showed expression in 20-57% of tumor cells. CONCLUSIONS: A poor biochemical response to octreotide may be associated with tumor expression of a truncated sst5 variant, despite abundant sst2a expression, suggesting an influence from variant sst5 on common sst signaling pathways. Furthermore, unrelated analgesic and biochemical effects of SSAs supported a complex pathogenesis of acromegaly-associated headache. Finally, assessment of truncated sst5 in addition to full length sst could be important for a choice of postoperative SSA treatment in somatotropinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Endocrinology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
- Department of Endocrinology, Skånes University Hospital, Malmö, Sweden.
- Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
- Department of Cell Biology, Physiology and Immunology, University of Córdoba, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofia, 14014 Córdoba, Spain; CIBER Fisiopat…
- Department of Medical Endocrinology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. Electronic address: ufeldt@rh.dk.
Förderung
- Arvid Nilsson's fund
Zitieren
APA
Marina, D., Burman, P., Klose, M., Casar-Borota, O., Luque, R. M., Castaño, J. P., & Feldt-Rasmussen, U. (2015). Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache. Growth Hormone & IGF Research, 25(5), 262-267. https://doi.org/10.1016/j.ghir.2015.07.003
Vancouver
Marina D, Burman P, Klose M, Casar-Borota O, Luque RM, Castaño JP, et al. Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache. Growth Hormone & IGF Research. 2015;25(5):262-267. doi:10.1016/j.ghir.2015.07.003
BibTeX
@article{Marina2015,
author = {Marina, Djordje and Burman, Pia and Klose, Marianne and Casar-Borota, Olivera and Luque, Raúl M and Castaño, Justo P and Feldt-Rasmussen, Ulla},
title = {Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache},
journal = {Growth Hormone & IGF Research},
year = {2015},
volume = {25},
number = {5},
pages = {262--267},
doi = {10.1016/j.ghir.2015.07.003}
}
EUVIMED